Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
Year: 2016
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
Institutions: Hebrew University of Jerusalem, Hadassah Medical Center
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2533098748
